News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Gupta Suneel
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 12,000 shares
@ $0 Paid exercise price by delivering 4,150 shares
@ $26.07, valued at
$108.2k
|
|
01/18/2023 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 20,625 shares
@ $0 Granted 123,750 options to buy
@ $12.17, valued at
$1.5M
|
|
04/26/2022 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Exercised 40,000 options to buy
@ $7.38, valued at
$295.2k
|
|
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2022 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 12,500 shares
@ $0 Granted 75,000 options to buy
@ $28.73, valued at
$2.2M
|
|
02/26/2021 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 12,000 shares
@ $0 Granted 80,000 options to buy
@ $23.57, valued at
$1.9M
|
|
02/28/2020 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 85,000 options to buy
@ $7.8, valued at
$663k
|
|
12/03/2019 |
4
| Gupta Suneel (EVP Clinical Operations) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Bought 30,000 shares
@ $5.13, valued at
$153.9k
|
|
03/04/2019 |
4
| Gupta Suneel (EVP Clinical Operations) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Granted 7,500 shares
@ $0 Granted 45,000 options to buy
@ $8.02, valued at
$360.9k
|
|
01/16/2019 |
4
| Gupta Suneel (EVP Clinical Operations) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns:
| Exercised 110,000 options to buy
@ $7.38, valued at
$811.8k
|
|
01/09/2019 |
3
| Gupta Suneel (EVP Clinical Operations) has filed a Form 3 on Protagonist Therapeutics, Inc |
|
|